Back

FDA warns Evolus over Jeuveau Instagram promotions, gives 15-day response deadline

Verifying
  • FDA officials warned Evolus over promotional Instagram posts for its Jeuveau prescription injectable.
  • Evolus shares fell 5.92% to $7.23 at publication, Benzinga Pro data showed.
  • The company received 15 working days to submit a compliance plan or stop distribution.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.